Skip to main content
Take the Quiz

Find your DBS System

Boston Scientific wants to be your partner on your Parkinson's disease (PD) journey, offering the latest technology, comfort options, and advances in DBS. For over a decade, we have been adapting and innovating our DBS system to the specific needs of those living with Parkinson's. Our personalized and precise system gives your doctor more control managing your symptoms and provides greater results from your procedure.1,2

The directional difference

From our long-lasting battery options to our thin, lightweight stimulators, your comfort and convenience was top of mind when creating our Vercise Genus™ DBS System. Learn more about our Directional DBS approach, which gives your doctor an incredibly sensitive and precise “steering wheel” to manage your care and hear from experts about the Boston Scientific difference.1,2

Why Boston Scientific?

Get to know your partner

Choosing the right DBS system is an important part of managing your PD. Our Directional DBS Systems** are available in 2 models, providing options to best fit your needs. Which type of battery is best for you will depend on your individual needs and preferences. If you are looking for a longer lasting option, then our rechargeable battery may be a better choice. If you are looking for the convenient option, then non-rechargeable may be a better choice.

Explore Our DBS Systems

Vercise Genus™ R16

  • Rechargeable
  • Lasts at least 15 years*

Vercise Genus™ R32

  • Rechargeable
  • The only four port battery available​

Vercise Genus™ P16

  • Non-rechargeable
  • Lasts about 3-5 years*

DBS Controller

  • Clear display
  • Large buttons
  • Future-ready technology

Vercise Genus™ R16

  • Rechargeable
  • 15 year warranty

Vercise Genus™ R32

  • Rechargeable
  • The only four port battery available​

Vercise Genus™ P16

  • Non-rechargeable
  • Lasts a minimum of 3 years with nominal settings*

DBS Controller​

  • Clear display
  • Large buttons
  • Future-ready technology

Vercise™ Cartesia™ X and HX Leads

  • The Most Coverage*** of any lead available​

Vercise™ Cartesia™ Directional Lead

  • Broad coverage
  • Precise control of stimulation

Ready for life

Can I stop my medicine? When can I expect my symptoms to ease? Can I travel with an implant? It’s normal to have questions as you begin a therapy like DBS. Your doctor and care team can walk you through every answer on your list. We’ve compiled a bank of resources to help you live and thrive with DBS.

DBS in Your Daily Life

Browse educational videos about DBS and PD

View Webinars

The Bluetooth® word mark and logos are registered trademarks owned by the Bluetooth SIG, Inc. and any use of such marks by Boston Scientific Neuromodulation Corporation is under license. 

*The battery life is dependent on the stimulation settings and conditions.

**A System that includes the Vercise™ PC, Vercise Gevia™, or Vercise Genus™ IPG and Vercise Cartesia™ Directional Lead(s) forms the Vercise Directional System

*** Information referenced from: ​

Medtronic. (2021). Medtronic Sensight™ Directional Lead Kit. https://www.medtronic.com/content/dam/emanuals/neuro/M982097A_a_013_view.pdf​

Abbott. (2021). Lead and Extensions Kits for Deep Brain Stimulation Systems.  Clinician’s Manual. https://manuals.eifu.abbott/en/detail-screen.html

References: 1. Boston Scientific Patient Information Brochure. A brighter future is taking shape: treating Parkinson’s disease with deep brain stimulation. Copyright 2021. 2. Eleopra R, Rinaldo S, Devigili G, et al. Brain impedance variation of directional leads implanted in subthalamic nuclei of Parkinsonian patients. Clin Neurophysiol. 2019;130(9):1562-1569. doi:10.1016/j.clinph.2019.06.001

Indication for Use:

The Boston Scientific Vercise™ PC, Vercise Gevia™, Vercise Genus™ Deep Brain Stimulation Systems are indicated for use in: 

  • Bilateral stimulation of the subthalamic nucleus (STN) as an adjunctive therapy in reducing some of the symptoms of moderate to advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.
  • Bilateral stimulation of the internal globus pallidus (GPi) as an adjunctive therapy in reducing some of the symptoms of advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.
  • Unilateral thalamic stimulation of the ventral intermediate nucleus (VIM) is indicated for the suppression of tremor in the upper extremity. The system is intended for use in patients who are diagnosed with essential tremor or parkinsonian tremor not adequately controlled by medications and where the tremor constitutes a significant functional disability.
  • Bilateral stimulation of the ventral intermediate nucleus (VIM) of the thalamus for the suppression of disabling upper extremity tremor in adult essential tremor patients whose tremor is not adequately controlled by medications and where the tremor constitutes a significant functional disability.

The Boston Scientific Vercise Deep Brain Stimulation System is indicated for use in:

  • Bilateral stimulation of the subthalamic nucleus (STN) as an adjunctive therapy in reducing some of the symptoms of moderate to advanced levodopa-responsive Parkinson’s disease (PD) that are not adequately controlled with medication.

Contraindications: The Boston Scientific Deep Brain Stimulation (DBS) Systems are not recommended for patients who will be exposed to the following procedures: Diathermy as either a treatment for a medical condition or as part of a surgical procedure, Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS).  The safety of these therapies in patients implanted with the Boston Scientific DBS System has not been established.  Patients implanted with Boston Scientific DBS Systems without ImageReady™ MRI Technology should not be exposed to Magnetic Resonance Imaging (MRI). Patients implanted with the Vercise Gevia or Vercise Genus or Vercise Genus Mixed System with M8 Adapter or Vercise DBS Lead-Only System (before Stimulator is implanted) with ImageReady MRI Technology are Full Body MR Conditional only when exposed to the MRI environment under the specific conditions defined in ImageReady MRI Guidelines for Boston Scientific DBS Systems.  Boston Scientific DBS Systems are not recommended for patients who are unable to operate the system or are poor surgical candidates or who experience unsuccessful test stimulation.  



Warnings: Unauthorized modification to the medical devices is prohibited.  You should not be exposed to high stimulation levels. High level of stimulation may damage brain tissue. Patients implanted with a Boston Scientific DBS System may be at risk for intracranial hemorrhages (bleeding in the brain) during DBS lead placement. Strong electromagnetic fields, such as power generators, security screeners or theft detection systems, can potentially turn the stimulator off, or cause unpredictable changes in stimulation. The system should not be charged while sleeping. If you notice new onset or worsening depression, changes in mood or behavior or impulse control, or have thoughts of suicide contact your physician or emergency services immediately.  Chemical burns may result if the Stimulator housing is ruptured or pierced.  The Boston Scientific DBS Systems may interfere with the operation of implanted stimulation devices, such as cardiac pacemakers, implanted cardioverter defibrillators, or medication delivery pumps. Patients should operate motorized vehicles or potentially dangerous machinery with caution.  It is unknown if the device may hurt an unborn baby. Your doctor may be able to provide additional information on the Boston Scientific DBS Systems.  For complete indications for use, contraindications, warnings, precautions, and side effects, see DBSandME.com or call (833) DBS-INFO or (833) 327-4636.


Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

NM-2199105-AA